Post-translational modifications in bladder cancer: Expanding the tumor target repertoire
Author:
Funder
Canadian Institutes of Health Research
Vancouver Prostate Centre
Publisher
Elsevier BV
Subject
Urology,Oncology
Reference110 articles.
1. The treated natural history of high risk superficial bladder cancer: 15-year outcome;Cookson;J Urol,1997
2. Contemporary management of stage T1 transitional cell carcinoma of the bladder;Sataa;Tunis Med,2005
3. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients;Stein;J Clin Oncol Off J Am Soc Clin Oncol,2001
4. Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer;Zargar;Eur Urol,2015
5. Pembrolizumab as second-line therapy for advanced urothelial carcinoma;Bellmunt;N Engl J Med,2017
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Lactylated Apolipoprotein C‐II Induces Immunotherapy Resistance by Promoting Extracellular Lipolysis;Advanced Science;2024-07-09
2. The Relationship Between Capsaicin in Chili Pepper and Cancer: A Comprehensive Insight;Clinical and Experimental Health Sciences;2024-03-28
3. Unraveling the Post-Translational Modifications and therapeutical approach in NSCLC pathogenesis;Translational Oncology;2023-07
4. The role of E3 ubiquitin ligases and deubiquitinases in bladder cancer development and immunotherapy;Frontiers in Immunology;2023-05-05
5. Functions and mechanisms of protein lysine butyrylation (Kbu): Therapeutic implications in human diseases;Genes & Diseases;2022-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3